Emerald Health Bioceuticals Inc. — Regulation A 1-A
Emerald Health Bioceuticals Inc. of SAN DIEGO, CA filed a Regulation A 1-A with the SEC on 2020-02-18. Aggregate offering: $50.0M (Tier 2). Industry: Other.
Offering
- Filed: 2020-02-18
- Form: 1-A
- Accession: 0001594062-20-000010
- Tier: Tier 2
- Total aggregate offering: $50.0M
- Issuer portion: $50.0M
- Price per security: $5.0000
- Securities offered: Equity (common or preferred stock)
- Audit status: Audited
- Auditor: Deloitte & Touche LLP
- Jurisdictions: 64 states/territories
Issuer
- CIK: 0001713164
- Organized in: DE
- Incorporated: 2015
- Address: 5910 PACIFIC CENTER BLVD., STE. 300, SAN DIEGO, CA, 92121
- Phone: 800-268-0719
- Employees: 6 full-time
Financial snapshot (as filed)
- Total assets: $2.7M
- Cash & equivalents: $426K
- Total liabilities: $7.5M
- Stockholder equity: $-4.7M
- Revenues: $654K
- Net income: $-2.3M
People (1)
| Name | Role | Location |
|---|
| Tu Diep | Signer | San Diego, CA |
Other Reg A filings by this issuer (1)
More